Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.
The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.
The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.
Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.
Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
2.
Two medications might work better for breast cancers that are resistant to one.
3.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
4.
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
5.
New research points out a promising strategy for treating metastatic medulloblastoma
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
3.
Obesity as a major risk factor for cancer
4.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
5.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation